Literature DB >> 20884210

The molecular pathology of central neurocytomas.

Ari J Kane1, Michael E Sughrue, Martin J Rutkowski, Tarik Tihan, Andrew T Parsa.   

Abstract

Central neurocytomas (CN) are rare tumors. Since their first description in 1982, the number of case reports and series has been rapidly increasing. Although they are considered low-grade neoplasms, they can be associated with an aggressive primary course or recurrence after resection. The cellular origin of central neurocytoma (CN) and the molecular events leading to tumorigenesis have been largely unknown. Here, we present a review of the scientific literature contributing to our knowledge of CN focusing on cellular origin and oncogenic alterations, and how these findings inform areas amenable to future research and therapeutic intervention. Our discussion is expanded to include important and related insights into the cellular origin and classification of central nervous system tumors. 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20884210     DOI: 10.1016/j.jocn.2010.06.004

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  3 in total

1.  Clinical course of central neurocytoma with malignant transformation-an indication for craniospinal irradiation.

Authors:  Petra Mozes; Erika Szanto; Laszlo Tiszlavicz; Pal Barzo; Adrienne Cserhati; Emese Fodor; Katalin Hideghety
Journal:  Pathol Oncol Res       Date:  2013-10-12       Impact factor: 3.201

2.  Atypical Neurocytoma: Dilemma in diagnosis and management.

Authors:  Gangadhar Vajrala; Piyush K Jain; Shitalkumar Surana; Sailaja Madigubba; Satish R Immaneni; Manas K Panigrahi
Journal:  Surg Neurol Int       Date:  2014-12-19

Review 3.  Central Neurocytoma: A Review of Clinical Management and Histopathologic Features.

Authors:  Seung J Lee; Timothy T Bui; Cheng Hao Jacky Chen; Carlito Lagman; Lawrance K Chung; Sabrin Sidhu; David J Seo; William H Yong; Todd L Siegal; Minsu Kim; Isaac Yang
Journal:  Brain Tumor Res Treat       Date:  2016-10-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.